LCS
BSX icon

Levin Capital Strategies’s Boston Scientific BSX Stock Holding History

Levin Capital Strategies’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
2,500
+1,500
+150% +$81.5K 0.01% 252
2026
Q1 		$62.8K Buy
+1,000
New +$80K ﹤0.01% 226

Other funds holding BSX

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Levin Capital Strategies's BSX Position: Q2 2026 in Review

Levin Capital Strategies reduced its Boston Scientific (BSX) stake by 4.6% in Q2 2026, selling an estimated $397K and leaving 151,635 shares worth $6.47M. The position accounts for 0.43% of the portfolio, ranked #63.

Levin Capital Strategies first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.97M in Q1 2026. 712 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Levin Capital Strategies held 151,635 shares of Boston Scientific worth $6.47M as of Q2 2026.
  • Levin Capital Strategies sold 7,305 Boston Scientific shares in Q2 2026, an estimated $397K.
  • Boston Scientific made up 0.43% of Levin Capital Strategies's portfolio in Q2 2026, its #63 holding.
  • Levin Capital Strategies first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Levin Capital Strategies's Boston Scientific position peaked at $9.97M in Q1 2026.
  • 712 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.